Cytori launches next-gen Celution cell therapy tech

Cytori Therapeutics (NSDQ:CYTX) said today that the next-gen version of its Celution cell therapy device is available for pre-order and that the 1st shipments will start in the 3rd quarter of 2017.

The San Diego-based company’s Celution system automates the extraction and concentration of autologous, clinical-grade adipose-derived regenerative cells. The next-gen Celution tech includes new hardware and software to improve performance and maintain compliance with global medical device and cell therapy standards, Cytori said.

Get the full story at our sister site, Drug Delivery Business News.

The post Cytori launches next-gen Celution cell therapy tech appeared first on MassDevice.

from MassDevice http://ift.tt/2rIUYOR